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Generation and analysis of MKOs. (A) MKOs were generated by crossing mice with a floxed PGC-1α allele to animals that transgenically express 
cre recombinase under the control of the myogenin promoter and MEF2C enhancer (Myo-Cre). (B) PGC-1α protein levels in gastrocnemius 
muscle were determined by Western blot. (C) Relative PGC-1α and PGC-1β mRNA expression was measured in different tissues by real-time 
PCR. Values are mean ± SEM. *P < 0.05, MKO versus control. n = 8 per group.
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Decreased mitochondrial gene expression and function in MKOs. (A) RNA was isolated from gastrocnemius muscle, and relative gene expression 
was measured by semiquantitative real-time PCR and normalized to 18S rRNA levels. NRF-1, nuclear respiratory factor 1; TFAM, mitochondrial 
transcription factor A; Ndufb5, NADH-ubiquinone oxidoreductase 1β subcomplex 5; Ndufs1, NADH-ubiquinone oxidoreductase Fe-S protein 1; 
Ndufv2, NADH-ubiquinone oxidoreductase flavoprotein 2; Cycs, cytochrome c; Atp5o, ATP synthase o subunit; ALAS-1, 5-aminolevulinate 
synthase. (B) Cross-sections of gastrocnemius were stained for Cox activity. (C) Cross-sections of gastrocnemius were stained for SDH activity. 
Scale bars: 250 μM. Values are mean ± SEM. *P < 0.05, MKO versus control. n = 8 per group.
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Decreased body fat and increased metabolic rate in MKOs. (A–C) Body weight (A), fat mass (B), and fat percentage (C) in 10-week-old mice 
fed regular chow or high-fat diet (HFD). (D) Growth curve of control mice and MKOs on a high-fat diet. (E) Weight gain (total, lean mass, and fat 
mass) in control and MKO animals fed a high-fat diet for 3 weeks. (F–H) Food intake (F), heat production (G), and oxygen consumption (VO2) 
per animal (H) were determined using a comprehensive laboratory animal monitoring system with control animals and MKOs on a high-fat diet. 
*P < 0.05, MKO versus control. n = 6 per group.
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MKOs have increased expression of several proinflammatory cytokines 













Impaired glucose homeostasis in MKOs. (A) Blood glucose was determined in fed and fasted mice (16 h, overnight) that were fed regular chow 
diet. (B) Blood glucose was determined in fed and fasted mice (16 h, overnight) that were fed a high-fat diet for 12 weeks. (C) Blood insulin 
was determined in nonfasted mice that were fed a high-fat diet for 12 weeks. (D and E) Glucose tolerance test (GTT) in regular chow–fed (D) 
and high-fat diet–fed (E) mice. Mice were given a bolus i.p. injection of 2 g/kg glucose, and blood glucose was subsequently measured at the 
indicated time points. (F) Insulin tolerance test (ITT) in high-fat diet–fed mice. Mice were given a bolus i.p. injection of 0.8 U/kg insulin, and blood 
glucose was subsequently measured at the indicated time points. (G and H) Glucose tolerance test in high-fat diet–fed mice. Mice were given 
a bolus i.p. injection of 2 g/kg glucose. Blood insulin (G) and glucose (H) were simultaneously measured at the indicated time points. *P < 0.05, 
MKO versus control. n = 8 per group.
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Systemic glucose fluxes and insulin sensitivity. (A) Hyperinsulinemic, 
euglycemic clamps were used to measure hepatic glucose output 
(HGO) under basal and clamped conditions. (B) Systemic glucose 
uptake, glycolysis, and glycogen synthesis were determined in hyper-
insulinemic, euglycemic clamps. Values are mean ± SEM. *P < 0.05, 
MKO versus control. n = 7 (controls); 10 (MKOs).
Figure 6
Islet morphology, insulin content, and glucose-stimulated insulin secretion. (A) Fixed pancreatic sections were immunostained for insulin (blue), 
glucagon (red), and somatostatin (green). Islets pictured are representative of control mice and MKOs shown at the same scale (original mag-
nification, ×40). Scale bars: 50 μM. (B) Quantitative analysis of β cell and non–β cell mass. Mass was measured by quantifying islets sections 
stained with markers for the different islet cell types. (C) β-Catenin staining of islet sections. Islet sections were stained with antibodies against 
insulin (red) and β-catenin (green) as well as DAPI (blue) to visualize nuclei. Original magnification, ×100. (D) Quantification of β cell size. The 
cellular area outlined by cell membrane stained for β-catenin was measured as the size of individual cells. (E) Insulin content of isolated islets 
was determined and normalized to the amount of DNA. (F) Insulin secretion normalized to the amount of DNA from isolated islets was determined 
under low-glucose (3.3 mM) and high-glucose (16.7 mM) conditions. Values are mean ± SEM. *P < 0.05, MKO versus control.
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Elevated markers for inflammation and ROS in MKOs. (A) Expression of several genes associated with inflammation in skeletal muscle were 
determined in gastrocnemius of control and MKO mice. MCP-1, monocyte chemotactic protein–1. (B) Serum IL-6 concentration was determined 
in control and MKO mice. (C and D) IL-6 inhibited glucose-stimulated insulin secretion in isolated islets from control mice (C) and MKOs (D). 
Isolated islets from control mice and MKOs were incubated for 24 h in RPMI media supplemented with 7 mM glucose and 10% FCS, followed by 
another 24-h incubation with vehicle or 400 pg/ml IL-6. At 48 h after isolation, static incubation experiments were performed. Stimulated insulin 
secretion was standardized by basal insulin secretion during preincubation period from same islet samples, and relative secreted insulin was 
normalized to the insulin secretion under 3.3 mM glucose. The glucose concentration used for stimulation is indicated. L-Arg, l-arginine (10 mM); 
GLP-1, glucagon-like peptide–1 (100 nM). Values are mean ± SD from 3–5 individual batches of islets. (E) ROS-detoxifying gene expression 
was analyzed in gastrocnemius of control mice and MKOs. SOD, superoxide dismutase; Ant, adenine nucleotide translocator; Gpx, glutathione 
peroxidase; UCP, uncoupling protein. Values are mean ± SEM. *P < 0.05, MKO versus control. n = 8 per group.
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specific knockouts exhibited clear differences from the whole-body 
PGC-1α heterozygous mice (Supplemental Figure 8).
Correlation between IL-6 and PGC-1α gene expression in skeletal muscle 













































Glucose and insulin homeostasis in SKM-Hets. (A and B) Glucose tolerance tests in control mice and SKM-Hets fed regular chow (A) or high-fat 
diet (B). (C and D) Insulin tolerance tests in control mice and SKM-Hets fed regular chow (C) or high-fat diet (D). (E and F) Glucose tolerance 
tests in control mice and SKM-Hets fed a high-fat diet with simultaneous determination of blood insulin (E) and blood glucose (F). (G and H) 
Determination of IL-6 mRNA levels in gastrocnemius (G) and serum IL-6 concentration (H) in control and SKM-Het mice. Values are mean ± SEM. 
*P < 0.05, SKM-Het versus control. n = 8 per group.
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Correlation between PGC-1α and IL-6 
gene expression in skeletal muscle of 
humans. (A–D) Linear regression analy-
sis of IL-6 and PGC-1α (PPARGC1A) 
gene expression (A), IL-6 gene expres-
sion and BMI (B), TNF-α and PGC-1α 
gene expression (C), and TNF-α gene 
expression and BMI (D) in skeletal mus-
cle of 42 human volunteers. Adjusted r2 
(r2adj) and P values are shown.
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Dual energy X-ray absorptiometry scan. Body fat content was determined 
by dual energy X-ray absorptiometry on anesthetized mice (Piximus II; 
Lunar Corp.).













































































































































































insulin  resistance  and  diabetes:  Potential  role 
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